Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool
Launched by UNIVERSITY HOSPITAL, MONTPELLIER · Sep 27, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how effective specific follow-up support is for adults recovering from alcohol use disorders after they leave the hospital. The researchers aim to see if regular motivational interviews—talks that encourage and support people in their recovery—can help those who have just completed treatment stay sober longer and reduce the chances of relapse. Participants will receive these motivational talks every two weeks for the first four months after their hospital stay, along with regular check-ins to monitor their progress.
To be eligible for this study, participants should be adults aged 18 and older who have been diagnosed with alcohol use disorder and are currently undergoing treatment in the hospital. They must be committed to staying completely sober and should have a way to communicate, like a phone. Participants in this trial can expect to receive extra support and encouragement, which may help them stay on track with their recovery over the following year. It’s also important to note that those who have serious medical issues or certain cognitive challenges may not be eligible to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • With alcohol use disorders defined by at least 2 DSM-V criteria for at least 12 months).
- • Being treated for withdrawal in hospital.
- • With a goal of complete abstinence.
- • With a means of communication (telephone).
- Exclusion Criteria:
- • Lack of understanding (written and spoken) of the French language.
- • Breach of HC withdrawal contract, following failure to comply with the rules of the addictology service and somatic complications of addiction.
- • Eviction from the department, discharge against medical advice during hospitalisation for withdrawal.
- • Proven cognitive problems compromising understanding of the implications of the study and the proposed follow-up. proposed follow-up.
- • Serious decompensated somatic pathology.
- • Non-membership or non-beneficiaries of a national health insurance scheme.
- • Person protected by law, under guardianship or curatorship.
- • Not having signed free and informed consent to participate in the research.
- • Simultaneous participation in another clinical trial.
About University Hospital, Montpellier
The University Hospital of Montpellier is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its commitment to patient-centered care, the hospital collaborates with multidisciplinary teams to explore cutting-edge treatments and therapies across various medical fields. By integrating clinical practice with education and research, the University Hospital of Montpellier aims to enhance health outcomes and contribute to the scientific community's understanding of complex medical conditions. Its robust infrastructure and expertise make it a pivotal player in the landscape of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montpellier, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported